Top

Published in:

01-01-2018 | Commentary

Can we HIIT cancer if we attack inflammation?

Authors: Efthymios Papadopoulos, Daniel Santa Mina

Published in: Cancer Causes & Control | Issue 1/2018

Abstract

Physical exercise offers numerous health-related benefits to individuals with cancer. Epidemiologic research has primarily been concerned with conventional exercise training that aligns with the recommendations of 150 min of moderate to vigorous physical activity per week. These recommendations are safe and effective at improving physical and psychosocial outcomes. Given the extensive evidence for generalized physical activity, researchers have begun to explore novel training regimens that may provide additional health benefits and/or improved adherence. Specifically, exercise at higher intensities may offer more or different benefits than conventional training approaches with potentially profound effects on the tumor microenvironment. This commentary focuses on the physiological effects of high-intensity interval training, also known as “HIIT,” and its potential antineoplastic properties.

Cormie P, Zopf EM, Zhang X, Schmitz KH (2017) The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects. Epidemiol Rev 39(1):71–92. https://doi.org/10.1093/epirev/mxx007 CrossRefPubMed

Rundqvist H, Augsten M, Strömberg A, Rullman E, Mijwel S, Kharaziha P et al (2013) Effect of acute exercise on prostate cancer cell growth. PLoS ONE 8(7):e67579. https://doi.org/10.1371/journal.pone.0067579 CrossRefPubMedPubMedCentral

Leung P-S, Aronson WJ, Ngo TH, Golding L, Barnard RJ (2004) Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro. J Appl Physiol 96(2):450–454. https://doi.org/10.1152/japplphysiol.00871.2003 CrossRefPubMed

Pedersen L, Idorn M, Pedersen BK, Straten P, Hojman P, Pedersen L et al (2016) Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell short article voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent. Cell Metab 23(3):1–9. https://doi.org/10.1016/j.cmet.2016.01.011 CrossRef

Courneya KS, Friedenreich CM, Quinney HA, Fields ALA, Jones LW, Fairey AS (2003) A randomized trial of exercise and quality of life in colorectal cancer survivors. Eur J Cancer Care (Engl) 12(4):347–357. https://doi.org/10.1046/j.1365-2354.2003.00437.x CrossRef

Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud’Homme DG et al (2009) Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 27(3):344–351. https://doi.org/10.1200/JCO.2007.15.4963 CrossRefPubMed

Devin JL, Sax AT, Hughes GI, Jenkins DG, Aitken JF, Chambers SK et al (2016) The influence of high-intensity compared with moderate-intensity exercise training on cardiorespiratory fitness and body composition in colorectal cancer survivors: a randomised controlled trial. J Cancer Surviv 10(3):467–479. https://doi.org/10.1007/s11764-015-0490-7 CrossRefPubMed

Toohey K, Pumpa KL, Arnolda L, Cooke J, Yip D, Craft PS et al (2016) A pilot study examining the effects of low-volume high-intensity interval training and continuous low to moderate intensity training on quality of life, functional capacity and cardiovascular risk factors in cancer survivors. PeerJ 4:e2613. https://doi.org/10.7717/peerj.2613 CrossRefPubMedPubMedCentral

Weston KS, Wisloff U, Coombes JS (2014) High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med 16:1227–1234. https://doi.org/10.1136/bjsports-2013-092576 CrossRef

10.

Milanovic Z, Sporis G, Weston M (2015) Effectiveness of high-intensity interval training (HIT) and continuous endurance training for VO2max improvements: a systematic review and meta-analysis of controlled trials. Sports Med 45(10):1469–1481. https://doi.org/10.1007/s40279-015-0365-0 CrossRefPubMed

11.

Thompson WR (2015) Worldwide survey of fitness trends for 2016: 10th anniversary edition. ACSM‘s Heal Fit J 19(6):9–18

12.

Grivennikov SI, Karin M (2011) Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 70(Suppl 1):i104–i108. https://doi.org/10.1136/ard.2010.140145 CrossRefPubMed

13.

Fu TC, Wang CH, Lin PS et al (2013) Aerobic interval training improves oxygen uptake efficiency by enhancing cerebral and muscular hemodynamics in patients with heart failure. Int J Cardiol 167(1):41–50. https://doi.org/10.1016/j.ijcard.2011.11.086 CrossRefPubMed

14.

Taniguchi K, Karin M (2014) IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol 26(1):54–74. https://doi.org/10.1016/j.smim.2014.01.001 CrossRefPubMed

15.

Liou G-Y, Storz P (2010) Reactive oxygen species in cancer. Free Radical Res. https://doi.org/10.3109/10715761003667554

16.

Mitranun W, Deerochanawong C, Tanaka H et al (2014) Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients. Scand J Med Sci Sports 24(2):e69–e76. https://doi.org/10.1111/sms.12112 CrossRefPubMed

17.

Qi X, Ng KT, Lian QZ, Liu XB, Li CX, Geng W et al (2014) Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma. Oncotarget 5(22):11103–11120. https://doi.org/10.18632/oncotarget.2549 CrossRefPubMedPubMedCentral

18.

Barrett CW, Ning W, Chen X, Smith JJ, Washington MK, Hill KE et al (2013) Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma. Cancer Res 73(3):1245–1255. https://doi.org/10.1158/0008-5472.CAN-12-3150 CrossRefPubMed

19.

Godsland IF (2009) Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) 118(5):315–332. https://doi.org/10.1042/CS20090399 CrossRef

20.

Jelleyman C, Yates T, O’Donovan G et al (2015) The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev 16(11):942–961. https://doi.org/10.1111/obr.12317 CrossRefPubMed

21.

Hood MS, Little JP, Tarnopolsky MA et al (2011) Low-volume interval training improves muscle oxidative capacity in sedentary adults. Med Sci Sports Exerc 43(10):1849–1856. https://doi.org/10.1249/MSS.0b013e3182199834 CrossRefPubMed

22.

Pecoraro M, Del Pizzo M, Marzocco S, Sorrentino R, Ciccarelli M, Iaccarino G et al (2016) Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity. Toxicol Appl Pharmacol 293:44–52. https://doi.org/10.1016/j.taap.2016.01.006 CrossRefPubMed

23.

Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM et al (2007) Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115(24):3086–3094. https://doi.org/10.1161/CIRCULATIONAHA.106.675041 CrossRefPubMed

24.

Angsutararux P, Luanpitpong S, Issaragrisil S (2015) Chemotherapy-induced cardiotoxicity: overview of the roles of oxidative stress. Oxid Med Cell Longev 2015:795602. https://doi.org/10.1155/2015/795602 CrossRefPubMedPubMedCentral

25.

Adams SC, Delorey DS, Davenport MH, Stickland MK, Fairey AS, North S et al (2017) Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: a phase 2 randomized controlled trial. Cancer. 2017. https://doi.org/10.1002/cncr.30859 PubMedCentral

26.

Adamsen L, Quist M, Andersen C, Moller T, Herrstedt J, Kronborg D et al (2009) Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ 2009 339:b3410. https://doi.org/10.1136/bmj.b3410

27.

Hwang CL, Yu CJ, Shih JY, Yang PC, Wu YT (2012) Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy. Support Care Cancer 20(12):3169–3177. https://doi.org/10.1007/s00520-012-1452-5 CrossRefPubMed

28.

Kampshoff CS, Chinapaw MJ, Brug J, Twisk JW, Schep G, Nijziel MR et al (2015) Randomized controlled trial of the effects of high intensity and low-to-moderate intensity exercise on physical fitness and fatigue in cancer survivors: results of the resistance and endurance exercise after chemotherapy (REACT) study. BMC Med 13:275. https://doi.org/10.1186/s12916-015-0513-2 CrossRefPubMedPubMedCentral

29.

Licker M, Karenovics W, Diaper J, Frésard I, Triponez F, Ellenberger C et al (2017) Short-term preoperative high-intensity interval training in patients awaiting lung cancer surgery: a randomized controlled trial. J Thorac Oncol 12(2):323–333. https://doi.org/10.1016/j.jtho.2016.09.125 CrossRefPubMed

30.

Midtgaard J, Christensen JF, Tolver A, Jones LW, Uth J, Rasmussen B et al (2013) Efficacy of multimodal exercise-based rehabilitation on physical activity, cardiorespiratory fitness, and patient-reported outcomes in cancer survivors: a randomized, controlled trial. Ann Oncol 24(9):2267–2273. https://doi.org/10.1093/annonc/mdt185 CrossRefPubMedPubMedCentral

31.

Schmitt J, Lindner N, Reuss-Borst M, Holmberg HC, Sperlich B (2016) A 3-week multimodal intervention involving high-intensity interval training in female cancer survivors: a randomized controlled trial. Physiol Rep. https://doi.org/10.14814/phy2.12693 PubMedPubMedCentral

32.

Schulz SV, Laszlo R, Otto S, Prokopchuk D, Schumann U, Ebner F et al (2017) Feasibility and effects of a combined adjuvant high-intensity interval/strength training in breast cancer patients: a single-center pilot study. Disabil Rehabil 21:1–8. https://doi.org/10.1080/09638288.2017.1300688 CrossRef

33.

Gleeson M (2007) Immune function in sport and exercise. J Appl Physiol 103:693–699. https://doi.org/10.1152/japplphysiol.00008.2007 CrossRefPubMed

34.

Weston M, Weston KL, Prentis JM, Snowden CP (2016) High-intensity interval training (HIT) for effective and time-efficient pre-surgical exercise interventions. Perioper Med [Internet] 5(1):2. Available from http://www.perioperativemedicinejournal.com/content/5/1/2

Title: Can we HIIT cancer if we attack inflammation?
Authors: Efthymios Papadopoulos
Daniel Santa Mina
Publication date: 01-01-2018
Publisher: Springer International Publishing
Published in: Cancer Causes & Control / Issue 1/2018
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-017-0983-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis

Determinants of prolactin in postmenopausal Chinese women in Singapore

Tree nut, peanut, and peanut butter intake and risk of postmenopausal breast cancer: The Netherlands Cohort Study

A framework to understand diet, physical activity, body weight, and cancer risk

Prostate cancer screening by prostate-specific antigen (PSA); a relevant approach for the small population of the Cayman Islands

Serum lipids and risk of obesity-related cancers in postmenopausal women

Keynote webinar | Spotlight on antibody–drug conjugates in cancer